Drug pricing deal change 'cuts NHS England's ability to provide care'


NHS England faces a ‘direct cut’ in its ability to provide care to patients as a result of a change to the deal that caps the price the government pays for branded medicines, a senior health economist has said.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here